Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoeitic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Authors :: Bazarbachi A
Schmid C
Labopin M
Beelen D
Wolfgang Blau I
Potter V
Niittyvuopio R
Socié G
Blaise D
Sanz J
Ciceri F
Abou Dalle I
Spyridonidis A
Bug G
Esteve J
Savani BN
Nagler A
Mohty M
Source :: Clinical cancer research : an official journal of the American Association for Cancer Research, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Publication Year :: 2020
Publisher :: AMER ASSOC CANCER RESEARCH, 2020.
Abstract: Relapsed acute myeloid leukemia (AML) post allogeneic-hematopoietic-cell-transplantation (allo-HCT) has a dismal prognosis.

Subjects :: surgical procedures, operative
endocrine system diseases
hemic and lymphatic diseases
neoplasms

ISSN :: 10780432
Database :: OpenAIRE
Journal :: Clinical cancer research : an official journal of the American Association for Cancer Research, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Accession number :: edsair.RECOLECTA.....d8e152268a41f0332255d241471a05d5

Tools